TVGNTevogen Bio Holdings Inc.

TVGN Stock Price, Valuation & Chart | Tevogen Bio Holdings Inc.

Compare

$7.170+0.00 (+0.00%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology TVGN intrinsic value TVGN calculated fair value vs price

Overview Financials Dividends Ratios

TVGN Historical price chart

TVGN Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization29.86M

PE Ratio-1.23

EPS-5.83

Trading Volume1.51K

Today's High/Low7.17/7.0

Dividend Yield0.00

52 Week High/Low49.5/3.64

Shares Outstanding4.16M

TVGN Financial Statement

TVGN Analyst ratings

TVGN Analysis & performance metrics

TVGN Company profile

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.…

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in…

TVGN Management team

Name

Position

Ryan H. Saadi M.D., M.P.H, M.P.H.CEO

Co-Founder, Chief Executive Officer & Chairperson

Tapan V. Shah

Head of Investor Relations & Corporate Development

Stephen Chen M.B.A.

Chief Technical Officer

Mittul MehtaCTO

Chief Information Officer & Head of Tevogen.ai

Kirti Desai CPACFO

Chief Financial Officer

Neal Flomenberg M.D.

Chief Scientific Officer and Global R&D Lead

Sadiq Khan M.B.A.

Chief Commercial Officer

David E. Banko CPA

Global Head of Government Affairs & Patient Access

Name

Position

Ryan H. Saadi M.D., M.P.H, M.P.H.CEO

Co-Founder, Chief Executive Officer & Chairperson

Tapan V. Shah

Head of Investor Relations & Corporate Development

Stephen Chen M.B.A.

Chief Technical Officer

Mittul MehtaCTO

Chief Information Officer & Head of Tevogen.ai

Kirti Desai CPACFO

Chief Financial Officer

Neal Flomenberg M.D.

Chief Scientific Officer and Global R&D Lead

Sadiq Khan M.B.A.

Chief Commercial Officer

David E. Banko CPA

Global Head of Government Affairs & Patient Access

Management Team

Ryan H. Saadi M.D., M.P.H, M.P.H.CEO

Co-Founder, Chief Executive Officer & Chairperson

Tapan V. Shah

Head of Investor Relations & Corporate Development

Stephen Chen M.B.A.

Chief Technical Officer

Mittul MehtaCTO

Chief Information Officer & Head of Tevogen.ai

Kirti Desai CPACFO

Chief Financial Officer

Neal Flomenberg M.D.

Chief Scientific Officer and Global R&D Lead

Sadiq Khan M.B.A.

Chief Commercial Officer

David E. Banko CPA

Global Head of Government Affairs & Patient Access

Management

Ryan H. Saadi M.D., M.P.H, M.P.H.CEO

Co-Founder, Chief Executive Officer & Chairperson

Tapan V. Shah

Head of Investor Relations & Corporate Development

Stephen Chen M.B.A.

Chief Technical Officer

Mittul MehtaCTO

Chief Information Officer & Head of Tevogen.ai

Kirti Desai CPACFO

Chief Financial Officer

Neal Flomenberg M.D.

Chief Scientific Officer and Global R&D Lead

Sadiq Khan M.B.A.

Chief Commercial Officer

David E. Banko CPA

Global Head of Government Affairs & Patient Access

Total 8 executives

TVGN Frequently asked questions

What is Tevogen Bio Holdings Inc. (TVGN) Stock Price?

Current stock price of Tevogen Bio Holdings Inc. (TVGN) stock is $7.170. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Tevogen Bio Holdings Inc. (TVGN) stock is 1.51K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Tevogen Bio Holdings Inc. (TVGN) stock price going up or down today?

The stock price of Tevogen Bio Holdings Inc. (TVGN) can change with earnings, company news, and overall market sentiment. Tevogen Bio Holdings Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Tevogen Bio Holdings Inc. stock expensive at its current price?

Whether Tevogen Bio Holdings Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for TVGN on this page is -1.23. EPS on this page is -5.83. Compare those figures with peers and growth expectations before deciding if the current Tevogen Bio Holdings Inc. price is justified.

How has the stock price of Tevogen Bio Holdings Inc. (TVGN) performed historically?

Historical performance for Tevogen Bio Holdings Inc. (TVGN) is shown on the price chart on this page. Review multi-period moves alongside volume to see how TVGN reacted to past earnings and market events.

Should I buy Tevogen Bio Holdings Inc. (TVGN) stock, at this price?

Buying Tevogen Bio Holdings Inc. (TVGN) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.